Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.
Gift yourself the perfect software before the holidays! Buy Online Today
Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.